For the quarter ending 2026-03-31, NKTR made $10,861,000 in revenue. -$44,904,000 in net income. Net profit margin of -413.44%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 10,861,000 | 20,784,500* | 11,790,000 | 11,175,000 |
| Cost of goods sold | - | 0* | 0 | 0 |
| Research and development (including 1,708 and 208 for the three months ended march 31, 2026 and 2025, respectively, from a related party) | 35,680,000 | 31,623,000* | 27,252,000 | 29,886,000 |
| General and administrative | 13,439,000 | 18,960,000* | 16,070,000 | 17,072,000 |
| Restructuring and impairment | 796,000 | 8,450,500* | 140,000 | 447,000 |
| Gain on sale of the huntsville manufacturing facility | - | 0* | - | - |
| Total operating costs and expenses | 49,915,000 | 59,033,500* | 43,462,000 | 47,405,000 |
| Loss from operations | -39,054,000 | -38,249,000* | -31,672,000 | -36,230,000 |
| Non-cash interest expense on liabilities related to the sales of future royalties | 7,942,000 | 9,022,500* | 6,047,000 | 5,394,000 |
| Interest income | 4,242,000 | 3,256,000* | 2,819,000 | 1,969,000 |
| Other income (expense), net (including income of 2 and 321 for the three months ended march 31, 2026 and 2025, respectively, from a related party) | -336,000 | 152,500* | -121,000 | 260,000 |
| Total non-operating income (expense), net | -4,036,000 | -5,614,000* | -3,349,000 | -3,165,000 |
| Loss before provision for income taxes and equity method investment | -43,090,000 | -43,863,000* | -35,021,000 | -39,395,000 |
| Provision for income taxes | 64,000 | 193,500* | -33,000 | -188,000 |
| Loss before equity method investment | -43,154,000 | -44,056,500* | -34,988,000 | -39,207,000 |
| Loss from equity method investment | -1,750,000 | -4,347,000* | -534,000 | -2,386,000 |
| Net loss | -44,904,000 | -48,403,500 | -35,522,000 | -41,593,000 |
| Basic EPS | -1.82 | -2.753 | -1.87 | -2.95 |
| Diluted EPS | -1.82 | -2.753 | -1.87 | -2.95 |
| Basic Average Shares | 24,736,066 | 17,578,924 | 18,946,559 | 14,087,307 |
| Diluted Average Shares | 24,736,066 | 17,578,924 | 18,946,559 | 14,087,307 |
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)